Taysha Gene Therapies (TSHA) PT Raised to $14 at Canaccord Genuity
Tweet Send to a Friend
(Updated - August 13, 2025 6:23 AM EDT)
Canaccord Genuity analyst Whitney IJem raised the price target on Taysha ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Whitney IJem raised the price target on Taysha ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
